Effects of epithelial growth factor receptor (EGFR) kinase inhibitors on genetically reconstituted mouse mammary glands

Author： Roth Daniel R   Roman Danielle   Cozens Robert   Brandt Ralf   Seewald Wolfgang   Greiner Brigitte   Wenger Fritz   Mamom Thanongsak   Germann Paul-Georg  

Publisher： Urban & Fischer

ISSN： 0940-2993

Source： Experimental and Toxicologic Pathology, Vol.55, Iss.4, 2003-11, pp. : 237-245

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Putting the Brakes on Cancer: Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors

By  

Pharmaceutical Innovation, Vol. 12, Iss. 1, 2002-12 ,pp. : 12-15

Adis International

Access to resources Recommend Favorite

Acneiform folliculitis associated with epidermal growth factor receptor (EGFR) inhibitors requires sympathetic treatment of mild, as well as severe, symptoms

By Adis International Limited  

Drugs & Therapy Perspectives, Vol. 25, Iss. 6, 2009-06 ,pp. : 24-26

Adis International

Access to resources Recommend Favorite

The risk of keratitis previously identified with panitumumab is now considered a class effect for all epidermal growth factor receptor (EGFR) inhibitors

By  

Reactions Weekly, Vol. 1, Iss. 1405, 2012-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

Docking and Molecular Dynamics Study on the Inhibitory Activity of Novel Inhibitors on Epidermal Growth Factor Receptor (EGFR)

By  

Medicinal Chemistry, Vol. 7, Iss. 1, 2011-01 ,pp. : 24-31

Bentham Science Publishers

Access to resources Recommend Favorite

QSAR and Molecular Docking Studies on a Series of Cinnamic Acid Analogues as Epidermal Growth Factor Receptor (EGFR) Inhibitors

By  

Letters in Drug Design & Discovery, Vol. 14, Iss. 1, 2017-01 ,pp. : 83-95

Bentham Science Publishers

Access to resources Recommend Favorite